Skip to main content
Orlagh M. Feeney on Muck Rack

Orlagh M. Feeney

Melbourne
As seen in: ACS Publications, Future Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Orlagh M.

Contact Orlagh M., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Nanobody-Mediated Cellular Uptake Maximizes the Potency of Polylysine Dendrimers While Preserving Solid Tumor Penetration

|
By Daniel Yuen, Orlagh M. Feeney, Leo Noi, Sudhir Shengule
| dx.doi.org
Open in Who Shared Issue with article?

Depolymerization of hyaluronan using PEGylated human recombinant hyaluronidase promotes nanoparticle tumor penetration

|
By Orlagh M. Feeney, Cameron J. Nowell, Daniel HS Brundel, Estelle JA Suys
| Future Medicine Verified
Daniel HS Brundel https://orcid.org/0000-0002-9856-3930 Drug Delivery, Disposition & Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia ARC Centre of Excellence in Convergent Bio-Nano Science & Technology, Monash Institute of Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia , Orlagh M Feeney **Author for correspondence: Tel.: +61 3 99039297; E-mail Address:...
Open in Who Shared Issue with article?

High-Density Lipoprotein Composition Influences Lymphatic Transport after Subcutaneous Administration

|
By Gracia Gracia, Enyuan Cao, Natalie L. Trevaskis, Orlagh M. Feeney
| ACS Publications
Interstitial administration (e.g., subcutaneous (SC) administration) of immunotherapies and vaccines within nanoparticles can improve access to lymph-resident immune cells, leading to enhanced efficacy and reduced off-target effects. Recently, endogenous high-density lipoproteins (HDLs) were found to return from peripheral tissue back to the systemic circulation via the lymphatic vessels and nodes.
Open in Who Shared Issue with article?
See all 3 articles